Judges Capital PLC
29 April 2008
29 April 2008
JUDGES CAPITAL PLC (the 'Company')
Director's Interests and Grant of Options
The Company announces that, on 28 April 2008, it granted options over an
aggregate of 77,000 new Ordinary Shares, comprising options over 6,550 new
Ordinary Shares under the Company's Unapproved Plan and options over 70,450 new
Ordinary Shares under the Company's Approved Plan of which options over 10,000
new Ordinary Shares were granted to Ralph Cohen, Finance Director of the
Company. The options are exercisable between three and 10 years from the date of
grant at an exercise price of 124p per share.
Ralph Cohen now holds in aggregate options over 20,000 new Ordinary Shares under
the Company's Approved Plan and he already holds options over 37,000 new
Ordinary Shares which were granted under the Company's Unapproved Plan.
Enquiries:
David Cicurel Judges Capital PLC 01342 323 600
Alex Borrelli Shore Capital 0207 408 4090
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.